Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study

Effective, low-cost therapeutics are needed to prevent and treat COVID-19. Severe COVID-19 disease is linked to excessive inflammation. Disulfiram is an approved oral drug used to treat alcohol use disorder that is a potent anti-inflammatory agent and an inhibitor of the viral proteases. We investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Fillmore, Nathanael, Bell, Steven, Shen, Ciyue, Nguyen, Vinh, La, Jennifer, Dubreuil, Maureen, Strymish, Judith, Brophy, Mary, Mehta, Gautam, Wu, Hao, Lieberman, Judy, Do, Nhan, Sander, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553043/
https://www.ncbi.nlm.nih.gov/pubmed/34710137
http://dx.doi.org/10.1371/journal.pone.0259061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553043/
https://www.ncbi.nlm.nih.gov/pubmed/34710137
http://dx.doi.org/10.1371/journal.pone.0259061

Ejemplares similares